PureWay, a healthcare waste disposal and compliance solutions provider, has been receiving increasing inbound interest and now has an advisor in place, though it is not actively pursuing a process, said CEO and co-founder Jeffery Miglicco.

The Katy, Texas-based company has “representation without a defined timeline” and is evaluating inbound interest opportunistically, Miglicco said.

Founded in 2013 by Miglicco, President Omar Al-Midani, and CFO Rodney Hanoon, PureWay remains 100% owned by its three co-founders.

Miglicco declined to disclose revenue but said 70%-75% is contracted, re-occurring revenue. PureWay is “highly profitable,” with approximately 30% annual growth forecast for the “foreseeable future,” he added.

PureWay provides regulated medical, pharmaceutical, hazardous, dental, and veterinary waste management services. It also offers workplace compliance training, documentation management, infection-control programs, software used to track waste shipments and compliance records, and sharps collection and mail-back disposal solutions.

The company serves a growing number of at-home injectors, Miglicco said. It operates throughout the US and Canada and services more than 500,000 sites annually, he added.

PureWay has grown organically to date but remains open to acquisition opportunities to gain customers or capabilities, particularly in states where permitting can be more challenging, including New York and New Jersey, Miglicco said.

Potential deals could be funded through a combination of cash, debt, and potentially private equity, the CEO noted.

Other healthcare waste providers include Sharps Compliance, Daniels Health, and MedPro Disposal, as well as larger environmental services companies such as WM, Clean Harbors, Republic Services, and Veolia, Miglicco said.

Miglicco said PureWay’s asset-light operating model differentiates it from many traditional healthcare waste providers. The company also focuses on at-home patients, hospital-at-home programs, and other small-quantity waste generators that he said traditional medical waste providers often overlook.

PureWay has developed a model to serve a large number of low-volume customers across a fragmented market, according to Miglicco.

The regulated waste industry remains active despite significant consolidation, the CEO said. WM entered the medical sector through its approximately USD 7.2bn acquisition of Stericycle in 2024. That same year, Clean Harbors purchased environmental and emergency response services provider HEPACO from Gryphon Investors for USD 400m in cash, with an expected multiple of 7.1x after synergies. Sharps Compliance – Miglicco’s previous employer – was taken private by Aurora Capital Partners for approximately USD 64m in 2022.

Miglicco said growth in home-based healthcare and self-administered therapies, including GLP-1 treatments, is driving demand for at-home sharps collection and disposal programs. Increasing regulation surrounding medical, pharmaceutical, hazardous, and sharps waste disposal is also driving demand for compliance solutions, he added.

Prior to co-founding PureWay, Miglicco served as senior director of sales at Sharps Compliance. Earlier in his career, he founded Prestige Mobile Media and held sales leadership positions at Marimon Business Systems and ASG Security.